Comments
Loading...
GlycoMimetics (GLYC) Forecast
NewsEarningsGlycoMimetics (GLYC) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestGlycoMimetics (NASDAQ:GLYC) Stock Quotes, Forecast and News Summary
GlycoMimetics Stock (NASDAQ: GLYC) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy GlycoMimetics (GLYC) stock?
You can purchase shares of GlycoMimetics (NASDAQ:GLYC) through any online brokerage.
Who are GlycoMimetics (GLYC) competitors?
Other companies in GlycoMimetics’s space includes: Eterna Therapeutics (NASDAQ:ERNA), HOOKIPA Pharma (NASDAQ:HOOK), CARISMA Therapeutics (NASDAQ:CARM), Evaxion Biotech (NASDAQ:EVAX) and Nanoviricides (AMEX:NNVC).
What is the forecast, or price target, for GlycoMimetics (GLYC) stock?
GlycoMimetics has a consensus price target of $12.00.
What is the current price for GlycoMimetics (GLYC)?
The stock price for GlycoMimetics (NASDAQ: GLYC) is $0.3008 last updated February 21, 2025 at 10:39 AM EST.
Does GlycoMimetics (GLYC) pay a dividend?
There are no upcoming dividends for GlycoMimetics.
When is GlycoMimetics (NASDAQ:GLYC) reporting earnings?
GlycoMimetics’s Q1 earnings are confirmed for Thursday, May 8, 2025.
Is GlycoMimetics (GLYC) going to split?
There is no upcoming split for GlycoMimetics.
What sector and industry does GlycoMimetics (GLYC) operate in?
GlycoMimetics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.